SS Innovations International (SSII) Asset Writedowns and Impairment (2024 - 2025)
SS Innovations International (SSII) reported Asset Writedowns and Impairment of $82942.0 for Q4 2025, down 64.71% on a YoY basis from $235030.0 in Q4 2024, and down 82.36% sequentially from $470249.0 in Q3 2025.
SS Innovations International (SSII) Asset Writedowns and Impairment (2024 - 2025) Analysis & Trends
SS Innovations International (SSII) has 2 years of Asset Writedowns and Impairment data on file, last reported at $82942.0 in Q4 2025.
- For the quarter ending Q4 2025, Asset Writedowns and Impairment fell 64.71% year-over-year to $82942.0; the trailing twelve-month figure through Dec 2025 stood at $324345.0 (down 66.06% YoY), and the FY2025 full-year result was $324345.0, down 66.06% from the prior year.
- Asset Writedowns and Impairment eased to $82942.0 in Q4 2025, from $470249.0 in the prior quarter.
- In the past five years, Asset Writedowns and Impairment ranged from a high of $470249.0 in Q3 2025 to a low of -$422711.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn |
| 10 | SS Innovations International | 776.19 Mn | 752.58 Mn | 5.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 82,942.00 |
| Dec 31, 2025 | 82,942.00 |
| Sep 30, 2025 | 470,249.00 |
| Sep 30, 2025 | 470,249.00 |
| Jun 30, 2025 | 193,865.00 |
| Jun 30, 2025 | 193,865.00 |
| Mar 31, 2025 | -422,711.00 |
| Mar 31, 2025 | -422,711.00 |
| Dec 31, 2024 | 235,030.00 |
| Dec 31, 2024 | 235,030.00 |
| Sep 30, 2024 | 147,684.00 |
| Sep 30, 2024 | 147,684.00 |
| Jun 30, 2024 | 183,718.00 |
| Jun 30, 2024 | 183,718.00 |
| Mar 31, 2024 | 389,330.00 |
| Mar 31, 2024 | 389,330.00 |